Embecta (EMBC) Common Equity (2020 - 2026)
Embecta (EMBC) posted Common Equity of -$626.1 million for Q1 2026, down 2.12% sequentially from -$613.1 million in Q4 2025, and up 14.96% YoY from -$544.6 million in Q1 2025.
Embecta (EMBC) Common Equity (2020 - 2026) Analysis & Trends
Embecta has reported Common Equity for 7 years, with the latest figure at -$626.1 million in Q1 2026.
- Quarterly Common Equity rose 14.96% year-over-year to -$626.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$626.1 million (up 14.96% YoY) and the FY2025 annual result came in at -$650.6 million, up 11.88% from the prior year.
- Common Equity retreated to -$626.1 million in Q1 2026 per EMBC's latest filing, from -$613.1 million in the prior quarter.
- Over five years, Common Equity peaked at -$613.1 million in Q4 2025 and troughed at -$967.5 million in Q1 2022.
- A 5-year average of -$772.1 million and a median of -$769.6 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2025: Common Equity slumped 266.61% in 2022, then climbed 20.25% in 2025.
- Over 5 years, Common Equity stood at -$836.1 million in 2022, then grew by 5.1% to -$793.5 million in 2023, then grew by 3.11% to -$768.8 million in 2024, then gained by 20.25% to -$613.1 million in 2025, then declined by 2.12% to -$626.1 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered -$626.1 million, -$613.1 million, and -$650.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Embecta | 319.59 Mn | 101.39 Mn | 153.30 Mn | -612.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -612.70 Mn |
| Mar 31, 2026 | -626.10 Mn |
| Dec 31, 2025 | -613.10 Mn |
| Sep 30, 2025 | -650.60 Mn |
| Jun 30, 2025 | -669.60 Mn |
| Mar 31, 2025 | -736.20 Mn |
| Dec 31, 2024 | -768.80 Mn |
| Sep 30, 2024 | -738.30 Mn |
| Jun 30, 2024 | -763.70 Mn |
| Mar 31, 2024 | -769.60 Mn |
| Dec 31, 2023 | -793.50 Mn |
| Sep 30, 2023 | -821.70 Mn |
| Jun 30, 2023 | -809.40 Mn |
| Mar 31, 2023 | -822.60 Mn |
| Dec 31, 2022 | -836.10 Mn |
| Sep 30, 2022 | -891.40 Mn |
| Jun 30, 2022 | -847.60 Mn |
| Mar 31, 2022 | -967.50 Mn |
| Dec 31, 2021 | 550.50 Mn |
| Sep 30, 2021 | 594.30 Mn |